Anavex extends CEO Missling's term to 2028 with $800k salary; PFO receives indefinite term and increased severance

ANAVEX LIFE SCIENCES CORP.

CEO Christopher Missling's employment term extended through July 5, 2028, with base salary $800,000 and target cash bonus of 20% of salary.
PFO Sandra Boenisch's employment made indefinite; base salary set at CAD $279,840 with 20% target bonus.
Boenisch's severance upon termination without cause increased from 6 to 12 months of base salary.
Both amendments effective July 3, 2025; Missling's annual equity grant remains at Compensation Committee's discretion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.